KAIROS PHARMA, LTD.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2023 | 87.2% | 87.2% | -187.8% |
| FY2024 | -54.5% | -54.5% | -45.1% |
| FY2025 | -85.9% | -85.9% | -83.3% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2023 | 87.2% | 87.2% | -187.8% |
| FY2024 | -54.5% | -54.5% | -45.1% |
| FY2025 | -85.9% | -85.9% | -83.3% |